18FY-LABELED ENHANCED MEMBRANE-SPECIFIC PROSTATE ANTIGEN INHIBITORS AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER

AR106243B1Active Publication Date: 2026-08-26DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20160103023
Authority / Receiving Office: AR · AR
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2016-08-04
Filing Date: 2016-09-30
Publication Date: 2026-08-26
Estimated Expiration: 2036-09-30

Application Information

Patent Timeline

04 Aug 2016

Priority

30 Sep 2016

Application

ARP20160103023

26 Aug 2026

Publication

AR106243B1

IPC: A61K38/03; A61P35/00

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present work is in the field of radiopharmaceuticals and their use in nuclear medicine as tracers and agents for imaging acquisition for various stages of prostate cancer.

Need to check novelty before this filing date? Find Prior Art

Claims

1. An isolated compound characterized in that it has Formula I: (FORMULA I) with: (TABLE) 8 Claims follow